AGE-LDL activates toll like receptor 4 pathway and promotes inflammatory cytokines production in renal tubular epithelial cells

International Journal of Biological Sciences

Volumn 9, Issue 1, 2013, Pages 94-107

  Cheng, Ao ^a   Dong, Yuanyuan ^a   Zhu, Fengxin ^a   Liu, Youhua ^a   Hou, Fan Fan ^a   Nie, Jing ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

AGE LDL; Il 6; Myd88; NF kB; Toll like receptor

Indexed keywords

ADVANCED GLYCATION END PRODUCT; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; LOW DENSITY LIPOPROTEIN; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

AGE-LDL; ARTICLE; CELL LINE; CYTOLOGY; DRUG EFFECT; EPITHELIUM CELL; GENETICS; HUMAN; IL-6.; KIDNEY TUBULE; METABOLISM; NF-ΚB; SIGNAL TRANSDUCTION;

AGE-LDL; IL-6.; MYD88; NF-ΚB; TOLL LIKE RECEPTOR;

CELL LINE; CYTOKINES; EPITHELIAL CELLS; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; KIDNEY TUBULES; LIPOPROTEINS, LDL; MYELOID DIFFERENTIATION FACTOR 88; NF-KAPPA B; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

EID: 84872186813     PISSN: 14492288     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijbs.5246     Document Type: Article

References (30)

1. Schlondorff DO: Overview of factors contributing to the pathophysiology of progressive renal disease. Kidney Int 2008; 74: 860-866.
2. Busch M, Franke S, Ruster C, Wolf G: Advanced glycation end-products and the kidney. Eur J Clin Invest 2010; 40: 742-755.
3. Miyata T, Iida Y, Horie K, Cai Z, Sugiyama S, Maeda K: Pathophysiology of advanced glycation end-products in renal failure. Nephrol Dial Transplant 1996; 11 Suppl 5: 27-30.
4. D'Agati V, Schmidt AM: RAGE and the pathogenesis of chronic kidney disease. Nat Rev Nephrol 2010; 6: 352-360.
5. Nosadini R, Tonolo G: Role of oxidized low density lipoproteins and free fatty acids in the pathogenesis of glomerulopathy and tubulointerstitial lesions in type 2 diabetes. Nutr Metab Cardiovasc Dis 2011; 21: 79-85.
6. Jinnouchi Y, Sano H, Nagai R, Hakamata H, Kodama T, Suzuki H, Yoshida M, Ueda S, Horiuchi S: Glycolaldehyde-modified low density lipoprotein leads macrophages to foam cells via the macrophage scavenger receptor. J Biochem 1998; 123: 1208-1217.
7. Anders HJ, Banas B, Schlondorff D: Signaling danger: toll-like receptors and their potential roles in kidney disease. J Am Soc Nephrol 2004; 15: 854-867.
8. Tsan MF, Gao B: Endogenous ligands of Toll-like receptors. J Leukoc Biol 2004; 76: 514-519.
9. Li F, Yang N, Zhang L, Tan H, Huang B, Liang Y, Chen M, Yu X: Increased expression of toll-like receptor 2 in rat diabetic nephropathy. Am J Nephrol 2010; 32: 179-186.
10. Devaraj S, Tobias P, Kasinath BS, Ramsamooj R, Afify A, Jialal I: Knockout of toll-like receptor-2 attenuates both the proinflammatory state of diabetes and incipient diabetic nephropathy. Arterioscler Thromb Vasc Biol 2011; 31: 1796-1804.
11. Devaraj S, Tobias P, Jialal I: Knockout of toll-like receptor-4 attenuates the pro-inflammatory state of diabetes. Cytokine 2011; 55: 441-445.
12. Lin M, Yiu WH, Wu HJ, Chan LY, Leung JC, Au WS, Chan KW, Lai KN, Tang SC: Toll-like receptor 4 promotes tubular inflammation in diabetic nephropathy. J Am Soc Nephrol 2012; 23: 86-102.
13. Sima AV, Botez GM, Stancu CS, Manea A, Raicu M, Simionescu M: Effect of irreversibly glycated LDL in human vascular smooth muscle cells: lipid loading, oxidative and inflammatory stress. J Cell Mol Med 2010; 14: 2790-2802.
14. Nivoit P, Wiernsperger N, Moulin P, Lagarde M, Renaudin C: Effect of glycated LDL on microvascular tone in mice: a comparative study with LDL modified in vitro or isolated from diabetic patients. Diabetologia 2003; 46: 1550-1558.
15. Krishnamurti U, Rondeau E, Sraer JD, Michael AF, Tsilibary EC: Alterations in human glomerular epithelial cells interacting with nonenzymatically glycosylated matrix. J Biol Chem 1997; 272: 27966-27970.
16. Jinnouchi Y, Sano H, Nagai R, Hakamata H, Kodama T, Suzuki H, Yoshida M, Ueda S, Horiuchi S: Glycolaldehyde-modified low density lipoprotein leads macrophages to foam cells via the macrophage scavenger receptor. J Biochem 1998; 123: 1208-1217.
17. Hou FF, Miyata T, Boyce J, Yuan Q, Chertow GM, Kay J, Schmidt AM, Owen WF: beta(2)-Microglobulin modified with advanced glycation end products delays monocyte apoptosis. Kidney Int 2001; 59: 990-1002.
18. Hodgkinson CP, Laxton RC, Patel K, Ye S: Advanced glycation end-product of low density lipoprotein activates the toll-like 4 receptor pathway implications for diabetic atherosclerosis. Arterioscler Thromb Vasc Biol 2008; 28: 2275-2281.
19. Rocuts F, Ma Y, Zhang X, Gao W, Yue Y, Vartanian T, Wang H: Carbon monoxide suppresses membrane expression of TLR4 via myeloid differentiation factor-2 in betaTC3 cells. J Immunol 2010; 185: 2134-2139.
20. Barton GM, Medzhitov R: Toll-like receptor signaling pathways. Science 2003; 300: 1524-1525.
21. Kumar H, Kawai T, Akira S: Toll-like receptors and innate immunity. Biochem Biophys Res Commun 2009; 388: 621-625.
22. Lu YC, Yeh WC, Ohashi PS: LPS/TLR4 signal transduction pathway. Cytokine 2008; 42: 145-151.
23. Rao KM: MAP kinase activation in macrophages. J Leukoc Biol 2001; 69: 3-10.
24. Garcia-Arnandis I, Guillen MI, Gomar F, Pelletier JP, Martel-Pelletier J, Alcaraz MJ: High mobility group box 1 potentiates the pro-inflammatory effects of interleukin-1beta in osteoarthritic synoviocytes. Arthritis Res Ther 2010; 12: R165.
25. Shen H, Tesar BM, Walker WE, Goldstein DR: Dual signaling of MyD88 and TRIF is critical for maximal TLR4-induced dendritic cell maturation. J Immunol 2008; 181: 1849-1858.
26. Park JS, Svetkauskaite D, He Q, Kim JY, Strassheim D, Ishizaka A, Abraham E: Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem 2004; 279: 7370-7377.
27. Bae YS, Lee JH, Choi SH, Kim S, Almazan F, Witztum JL, Miller YI: Macrophages generate reactive oxygen species in response to minimally oxidized low-density lipoprotein: toll-like receptor 4- and spleen tyrosine kinase-dependent activation of NADPH oxidase 2. Circ Res 2009; 104: 210-218.
28. Su X, Ao L, Shi Y, Johnson TR, Fullerton DA, Meng X: Oxidized low density lipoprotein induces bone morphogenetic protein-2 in coronary artery endothelial cells via Toll-like receptors 2 and 4. J Biol Chem 2011; 286: 12213-12220.
29. Hou FF, Ren H, Owen WF, Jr., Guo ZJ, Chen PY, Schmidt AM, Miyata T, Zhang X: Enhanced expression of receptor for advanced glycation end products in chronic kidney disease. J Am Soc Nephrol 2004; 15: 1889-1896.
30. Sakaguchi M, Murata H, Yamamoto K, Ono T, Sakaguchi Y, Motoyama A, Hibino T, Kataoka K, Huh NH: TIRAP, an adaptor protein for TLR2/4, transduces a signal from RAGE phosphorylated upon ligand binding. PLoS One 2011; 6: e23132.